Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Polifleks Isolen-S is an intravenous electrolyte solution designed to treat and prevent water and salt deficiencies (dehydration) in the body. It contains a balanced combination of essential electrolytes including sodium chloride, potassium chloride, sodium acetate trihydrate, magnesium chloride hexahydrate, sodium gluconate, monobasic potassium phosphate, and dibasic sodium phosphate heptahydrate. This multi-component solution works by replenishing lost fluids and electrolytes, thereby restoring and maintaining the body's crucial fluid balance, osmotic pressure, and acid-base homeostasis. It is manufactured by Polifarma İlaç San. ve Tic. A.Ş. and is indicated for various conditions involving fluid and electrolyte disturbances such as burns, diarrhea, excessive sweating, endocrine disorders, and metabolic acidosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Polifleks Isolen-S.